Section Arrow
HAE.NYSE
- Haemonetics Corp
Quotes are at least 15-min delayed:2025/04/29 23:56 EDT
Last
 63.97
+1.33 (+2.12%)
Day High 
64.24 
Prev. Close
62.64 
1-M High
64.22 
Volume 
530.44K 
Bid
36.12
Ask
81
Day Low
62.08 
Open
62.82 
1-M Low
55.3 
Market Cap 
3.15B 
Currency USD 
P/E 24.66 
%Yield -- 
10-SMA 59.53 
20-SMA 60.22 
50-SMA 63.13 
52-W High 97.97 
52-W Low 55.3 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.54/5.58
Enterprise Value
3.94B
Balance Sheet
Book Value Per Share
18.05
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
993.20M
Operating Revenue Per Share
24.67
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BSXBoston Scientific Corp102.74+0.56+0.55%82.3PE
PACBPacific Biosciences of California1.11-0.02-1.77%-- 
MDTMedtronic plc84.6+0.56+0.67%25.62PE
EWEdwards Lifesciences Corp76.28+0.74+0.98%32.28PE
ABTAbbott Laboratories130.5+0.97+0.75%16.95PE
Quotes are at least 15-min delayed:2025/04/29 23:56 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, thecompany operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.